Authors (Year of publication) | Number of patients with EDP | Mortality [%] | Morbidity [%] | Survival |
---|---|---|---|---|
Ozaki[32] (1996) | 15 | 0 | NA | 5-YS: 29% |
Mayumi[33] (1997) | 6 | 0 | NA | 1-YS: 40%#; 3-YS: 20%# |
Sasson[34] (2002) | 37 | 1.7 | 38 | 16 months (median)*; 5-YS: 26% |
Shoup[29] (2003) | 22 | 0 | NA | 15.9 months (median)* #; 5-YS: 22%,10-YS: 18%* # |
Gagandeep[35] (2006) | 3 | 0 | NA | 1-YS: 100% |
Shimada[36] (2006) | 88 | 0 | NA | 22 months (median); 5-YS: 19% |
Teh[37] (2007) | 33 | 3 | 36 | 5-YS: 36% (endocrine tumors) |
Hirano[31] (2007) | 23 | 0 | 48 | 21 months (median); 5-YS: 42% |
Mohebati[38] (2008) | 41 | 0 | 24 | 32.7 months (median) |
Overall | 268 | 0.5 | 36.5 | Â |